Diana Kerwin

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (8)

Michael Howell

Professor and Vice Chair

University of Minnesota

UNITED STATES

View details

Fabrizio Tagliavini

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Ging-Yuek Hsiung

The University of British Columbia

CANADA

View details

Alexander Pantelyat

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Paul Tuite

Professor

University of Minnesota

UNITED STATES

View details

Jean-Pierre Brion

Director of LHNN, Professor

Université libre de Bruxelles

BELGIUM

View details

Charlene Supnet

Associate Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

Michael Gold

Chief R&D Officer

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Diana Kerwin

Research Interests

Explore related searches

Contact this professor

Articles (10)

Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease

Bio‐Hermes study topline results: Aß 40/42 and p‐tau181/217/231 blood‐based biomarkers compared to amyloid PET and CSF in a diverse, community‐based population

Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease

Evaluation of noise regression techniques in resting-state fMRI studies using data of 434 older adults

Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration.

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care

Current directions in tau research: Highlights from Tau 2020

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer’s Disease Study (rrAD)

Collaborators (8)

Michael Howell

Fabrizio Tagliavini

Ging-Yuek Hsiung

Alexander Pantelyat

Paul Tuite

Jean-Pierre Brion

Charlene Supnet

Michael Gold

Make your next move.